NCT02234999View on ClinicalTrials.gov

Radiolabeled Study of CC-122 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

September 23, 2014

Primary Completion Date

October 8, 2014

Study Completion Date

October 8, 2014

Conditions

Healthy Volunteers

Interventions

DRUG

CC-122

3mg \[14C\]-CC-122 will be administered as a single dose

Trial Locations (1)

53704

Covance Clinical Research Unit Inc, Madison

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Celgene

INDUSTRY